Renovion
Completion of $8.1 Million Financing Round Enables Clinical Programs in Chronic Lung Diseases
Poised for pivotal lung transplant trial in U.S. Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of...
top of page
News
Search
Renovion
- Mar 1, 2018
- 2 min
Dr. Robert Ryan joins Renovion, Inc. Board of Directors
Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung...
Renovion
- Dec 20, 2017
- 2 min
Renovion Elects Derek Winstanly as Chairman of Board of Directors
Renovion, Inc. ("Renovion"), an early stage drug development company targeting a novel treatment for lung transplant patients and other...
Renovion
- Jan 6, 2017
- 2 min
Renovion Receives Orphan Designation for ARINA-1 for the treatment of Lung Dysfunction
Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...
Renovion
- Sep 22, 2016
- 2 min
Chapel Hill startups represent in D.C.
Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. On Tuesday,...
Renovion
- Sep 19, 2016
- 3 min
‘Spirit of Innovation’
Of the more than 800 startups created at universities across the country this year, only 35 have been handpicked as the best and earned...
Renovion
- Sep 1, 2016
- 2 min
Entrepreneur with GSK roots targets lung transplant survival rates with UNC technology
In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...
Renovion
- Feb 1, 2016
- 2 min
Renovion Receives Patent Allowance for Novel Therapy
- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...
bottom of page